MFAT for Joint and Nerve Pain: What the Evidence Shows
Short Answer
- Microfragmented fat (MFAT) is a stem cell therapy that uses a small amount of a patient's own fat, processed mechanically the same day, to support healing in painful joints, tendons, ligaments, and nerves
- The processed fat clusters act as a scaffold that carries stem and stromal cells plus anti-inflammatory signals into the injured tissue, delivered by injection under image guidance
- Research indicates a single MFAT injection can produce meaningful improvement in knee arthritis pain lasting 12 months
In short: MFAT is a same-day, image-guided stem cell injection that uses your own fat to support healing in chronic joint, tendon, and nerve-entrapment pain.
If your knee, hip, shoulder, or nerve-related pain has outlasted every treatment you have tried and you live in Gilbert, Chandler, or Queen Creek, this guide walks through non-surgical MFAT stem cell injections for chronic joint and nerve pain and what the research actually supports.
You have likely been through the usual sequence: physical therapy, maybe chiropractic care, then a cortisone injection that helped for a while and stopped. Now someone has mentioned joint replacement or another surgery. But chronic pain that keeps returning after symptom-focused treatments may be coming from structures that were never properly identified. Treating those structures directly is where orthobiologic options like MFAT come in.
Microfragmented adipose tissue (MFAT) is a stem cell therapy that uses a small sample of the patient's own fat, processed mechanically the same day into small tissue clusters and injected under image guidance at Regenerative Performance in Gilbert, AZ to support healing in arthritic joints, tendons, and ligaments. Because the fat is resized with mechanical force rather than digested with enzymes, MFAT keeps the tissue's natural structure, which separates it from enzymatically produced products such as stromal vascular fraction. The published research is strongest for knee and hip osteoarthritis. Evidence for tendon, fascia, and nerve applications is still early.
If you have chronic joint or nerve pain that has not improved with PT, chiropractic, or cortisone, the next step is a detailed, in-person assessment to identify the exact tissues causing your pain and review non-surgical orthobiologic options like Platelet-Rich Plasma (PRP) and stem cell therapy.
Schedule a 2-hour evaluation for your chronic joint or nerve pain at our Gilbert, AZ clinic (also serving Chandler, Mesa, Queen Creek, and the greater Phoenix area).
We limit how many new regenerative patients we accept each month to devote sufficient time and attention to each case.
At our Gilbert clinic, we use ultrasound-guided MFAT injections as one of three non-surgical stem cell therapy options we offer for chronic joint and nerve-related pain. Many of our stem cell patients travel from across Arizona and out of state after exhausting conventional care, most often for chronic joint pain that has not responded to properly performed conservative treatment.
Key Facts About Microfragmented Fat (MFAT)
Here is what you need to know about MFAT before deciding whether it is worth exploring for your chronic pain.
- What MFAT is: Microfragmented adipose tissue (MFAT), sometimes called microfat, is a stem cell therapy that uses a small amount of your own fat, mechanically resized the same day into cell-rich clusters and injected where your pain is coming from
- Who it helps: Adults with chronic pain originating from joints, tendons, ligaments, or specific nerve entrapments, knees, hips, and shoulders among them, that has not improved with physical therapy, chiropractic care, medications, or cortisone
- How it works: The fat clusters carry mesenchymal stem and stromal cells that can support cartilage, bone, and connective tissue repair and produce growth factors that influence these tissues, injected under ultrasound guidance, with x-ray confirmation added for certain joints
- Goal of treatment: Support healing in the structures generating your pain, rather than suppressing the symptoms
- Patient satisfaction: Among stem cell treatments in our registry, 94% of cases with a completed six-month satisfaction survey were rated satisfied or extremely satisfied
- Timeline: Most patients begin to notice changes within 4 weeks, with the majority of improvement over the first 6 months and continued gains possible up to a year. Individual results may vary
- Typical treatments: We start with one treatment and track your individual response over a full year. In a small percentage of cases, a booster PRP injection is considered around the 3 to 6 month mark based on how you responded
- Where: Regenerative Performance in Gilbert, AZ, serving the East Valley and the greater Phoenix area
- Next step: Call 480-508-4226 to schedule a 2-hour evaluation for chronic joint or nerve pain in Gilbert, AZ
This page is especially useful if you want a stem cell option but would rather avoid a bone marrow draw, or you have been told your arthritis is too advanced for another cortisone injection and you are researching what comes next.
What is microfragmented adipose tissue (MFAT)?
Microfragmented adipose tissue (MFAT) is body fat that has been harvested during a mini lipoaspiration and mechanically broken down into tiny clusters, keeping the tissue's natural architecture intact. The MFAT is then injected into damaged joints, tendons, or other painful structures.
Fat earned its place in regenerative medicine because it is one of the body's most accessible and cell-rich sources of mesenchymal stem and stromal cells (Fu et al., 2025).
At Regenerative Performance, MFAT is one of three stem cell therapy options: the others are bone marrow concentrate (BMAC) and a culture-expanded, adipose-derived option available through the federal Right to Try Act. All three are genuine stem cell therapy because all three deliver your own stem and stromal cells. PRP, by contrast, concentrates platelets and growth factors and is not a stem cell treatment.
You will also see the term nanofat: fat that has been mechanically emulsified into a finer, more easily injectable preparation (Jeyaraman et al., 2021). The key difference from microfat is structural: nanofat is emulsified down to the point that its larger tissue clusters and stromal scaffold are broken apart, so it carries a higher concentration of stem and stromal cells in suspension but loses the intact structural matrix that microfat retains (Cicione et al., 2023). We offer both, and in practice we often mix microfat and nanofat in the same treatment.
How does an MFAT injection work?
An MFAT injection works by injecting your own processed fat directly into the damaged structure, where it acts as a living scaffold that supports the tissue's stalled healing response. The same-day mechanical processing is what separates MFAT from other fat-derived products, and it shapes both the biology and the rules that govern it.
Mechanical processing, not enzymes
The defining feature of MFAT is how it is made. The fat is resized using only mild mechanical forces, with no enzymes, and nothing is cultured, meaning grown in a lab over time. That matters for two reasons. Biologically, it preserves the fat's natural support structure and the cells living inside it. Legally, mechanical processing keeps MFAT inside the FDA's minimal-manipulation framework for same-day use of your own tissue.
This is the key distinction from stromal vascular fraction (SVF), a different fat-derived product created by digesting fat with enzymes. SVF is considered more than minimally manipulated and sits on a different regulatory footing. We do not offer SVF, and results from SVF studies should never be read as MFAT results.
What the fat delivers
Once injected, the fat does two jobs described in the mechanism research on joint injury: it acts as a scaffold that supports the damaged tissue, and it delivers mesenchymal stem and stromal cells that can support tissue repair. Research also suggests the microfat releases anti-inflammatory signals that stay active in the tissue for weeks (Fu et al., 2025).
Why we combine fat with PRP
At our clinic, fat is typically combined with PRP in the same treatment. A 2025 review by Everts et al. in the International Journal of Molecular Sciences suggests platelet growth factors and fat-derived cells act through different, complementary mechanisms that support each other.
Schedule a 2-hour evaluation for your chronic joint or nerve pain at our Gilbert, AZ clinic.
What does the research say about MFAT for joint pain?
The research on MFAT for joint pain is most developed at the knee and hip, where randomized and observational studies suggest meaningful improvement for many patients, alongside real limitations. The strongest data come from randomized trials at the knee, with observational support at the hip.
Published research tends to lag behind clinical practice, as it does in much of medicine. Clinically, we see better and more consistent results than the studies below have measured so far, and it will likely take time for the research to catch up. Here is what the published evidence currently shows:
- A 2022 randomized controlled trial in the Orthopaedic Journal of Sports Medicine by Baria et al. indicates that a single MFAT injection and a single PRP injection for knee osteoarthritis each improved pain scores by roughly 3 points (on a 0-10 scale) at 6 months. In the trial, 67% of PRP patients and 71% of MFAT patients rated their symptom state as acceptable, with no difference detected between the treatments.
- A 2025 saline-controlled randomized trial in Arthroscopy by Richter et al. indicates MFAT patients improved from baseline at every follow-up starting at 2 weeks after injection, with the improvement continuing to build over time; the improvement over saline was strongest, and statistically confirmed, at 6 months and 1 year. A comparison corticosteroid group told a different story: relief peaked early and then faded. No complications were reported beyond the expected mild pain and bruising at the fat-harvest site.
- A 2022 randomized trial in the American Journal of Sports Medicine by Zaffagnini et al. followed MFAT and PRP patients for 2 years and suggests both produced significant, comparable improvement throughout. Patients with moderate to severe arthritis who received MFAT were more likely to reach a meaningful knee-function improvement than those who received PRP at 6 months (75% vs 35%). It is one exploratory data point, not proof, that MFAT may have an edge for more advanced arthritis.
- A 2024 meta-analysis by Veronesi et al. in the Journal of Clinical Medicine pooled the comparative studies. The results suggest fat-derived treatments perform comparably to PRP for knee osteoarthritis. The authors concluded the overall evidence quality is still low and, given the added cost, invasiveness, and potential side effects of a fat harvest, advised against using it before PRP as a first-line injection.
- The most current systematic review of randomized trials, published in Frontiers in Medicine by Batista et al., looked at 19 randomized trials of fat-derived treatments for knee arthritis. Results across the MFAT trials were mixed, with limited evidence of structural cartilage change, and one double-blind, placebo-controlled trial suggested no advantage over saline at 24 months. No serious adverse events were reported across all 19 trials.
- At the hip, a 1-year observational study by Heidari et al. in the Journal of Clinical Medicine suggests that among patients who received MFAT alone and completed one-year follow-up, 63% improved in pain and 81% improved in function. The study's analysis suggests MFAT plus PRP performed about as well as MFAT alone, and the study reported no infections or blood-clot complications in either group.
Taken together, the research indicates MFAT is a legitimate, well-tolerated option for knee and hip arthritis, with benefit that tends to appear within weeks and hold or grow through the first year, not a miracle treatment with proven superiority.
MFAT vs PRP: which is right for you?
The head-to-head randomized trial (Baria et al., 2022) indicates MFAT and PRP produce similar knee arthritis results at 6 months, with no difference detected between them. The choice is less about which one wins and more about your diagnosis, your severity, and your circumstances.
One finding favors MFAT, though it is still preliminary. A separate 2-year randomized trial (Zaffagnini et al., 2022) indicates that in patients with moderate to severe knee arthritis specifically, more people who received MFAT reported a meaningful improvement in knee function at 6 months than people who received PRP. That difference did not show up on a second measure of knee pain, and it was no longer present at 12 months. The study's authors describe the finding as exploratory rather than settled. We take it as one data point, not proof, that MFAT may have an edge for patients with more advanced arthritis.
PRP is simpler for the patient, since it starts with a blood draw rather than a fat harvest. The meta-analysis authors reserve fat-derived treatment as a second-line option behind PRP, citing the added invasiveness, potential side effects, and cost of a fat harvest. Stem cell therapy, whether fat-derived or bone-marrow-derived, is the stronger treatment we reach for when the damage is more extensive. In our experience, PRP can accomplish similar pain relief in most situations but usually requires more treatments to get there.
Body weight is one factor the research says to consider when deciding between MFAT or PRP. A 2024 analysis by Baria et al. indicates that among patients who received MFAT, a higher body mass index (BMI) was linked to lower one-year scores for daily function and quality of life; that same link was not seen among patients who received PRP. For patients with a higher BMI, that nuance can tilt the decision toward PRP or toward bone marrow.
MFAT vs BMAC: two stem cell options
MFAT and bone marrow concentrate (BMAC) are our two same-day, in-clinic stem cell therapy options, and most of the time the choice between them comes down to patient preference. The head-to-head data is limited: in the only direct comparison we are aware of, a retrospective study, meaning one that looked back at existing patient records, by Mautner et al. in Stem Cells Translational Medicine, the data suggest both groups improved significantly after treatment for knee arthritis with no significant difference between them. So this choice is clinical judgment, not proven by head-to-head research.
Here are things we consider when deciding between fat or bone marrow:
- Bone marrow edema, or arthritis that warrants subchondral injections. Swelling within the bone beneath the cartilage often calls for injecting directly into the bone itself, and those subchondral injections can only be done with bone marrow concentrate and PRP, not fat
- When bone marrow is not a good option for you, for example if you have osteoporosis, fat becomes the better source
- Sending cells for lab expansion (PSC). If you are having your harvested cells expanded, meaning grown into larger numbers, at an outside lab through our PSC pathway (the culture-expanded, Right to Try option described above), that route requires a fat harvest, not bone marrow
- Preference. Some patients simply prefer a small-volume lipoaspiration over a bone marrow draw, or the reverse
- Large tears or gaps in tissue, such as a large rotator cuff tear, where the extra physical volume fat provides may be an advantage
In select cases we combine bone marrow, fat, and PRP in one treatment, targeted by structure: a subchondral injection may get BMC plus PRP while the soft tissue in the same case gets fat plus PRP. You can read how we approach bone marrow cases in our article on BMC and PRP for rotator cuff tears.
Can MFAT help nerve pain and other chronic pain?
MFAT can be used across most chronic pain structures we treat: joints, tendons, ligaments, fascia, scar tissue, and specific nerve entrapments. The strength of the supporting evidence differs by tissue, and the difference matters.
For joints, the evidence base above is real and growing. For tendon, ligament, fascia, and scar applications, published MFAT-specific research is thinner, and our use there rests on the same mechanism plus clinical judgment about the individual case.
For nerve pain, MFAT is one of six injectate options we use for nerve hydrodissection in specific entrapments such as carpal tunnel syndrome, but there are currently no published clinical trials of MFAT for nerve entrapments. The MFAT evidence base is concentrated in osteoarthritis, and joint results cannot be borrowed as if they applied to nerves. Nothing about the mechanism suggests fat-derived cells turn into nerve tissue; the goal is supporting the environment around a compressed nerve after it has been released with fluid. If you want the full picture of that procedure, start with our complete guide to nerve hydrodissection.
What to Expect at Our Gilbert, AZ Clinic
What to expect at our Gilbert, AZ clinic is a diagnosis-first process: a 2-hour evaluation, an individualized plan, the same-day MFAT procedure, and structured follow-up over the following year.
The 2-Hour Evaluation
Every new patient starts with a detailed 2-hour evaluation that includes a thorough history and a hands-on physical examination with specific tests for the joints, tendons, and nerves in your painful region, plus diagnostic ultrasound when indicated. One tool we rely on is sonopalpation: pressing directly under the ultrasound probe to see whether a suspicious-looking tissue reproduces your familiar pain, because that helps identify which structure is most likely contributing when we put it together with your history and, when needed, imaging.
The primary purpose of this evaluation is to identify the specific tissues causing your pain. This step is crucial because proper diagnosis is the single most important factor in regenerative treatment success.
Individualized Treatment Plan
Based on the evaluation, we determine whether you are a candidate for MFAT, bone marrow concentrate, PRP, or another regenerative approach. From there, we develop an orthobiologic plan specific to your case, including which structures will be treated, the expected timeline, and your role in recovery.
Because the first three months after a stem cell injection are the critical window where most healing occurs, we typically recommend supplements and peptides to support the healing process. Our goal is to give your body every advantage during that healing window.
Ultrasound-Guided MFAT Injection
On your treatment day, we harvest a small volume of fat, usually 30 to 120 mL, from the lower abdomen or upper glutes using a gentle water-assisted system (BodyJet Eco), then resize it mechanically with the BioSL Adinizer the same day. We also draw blood to prepare PRP, because at our clinic fat is typically combined with PRP, and we often mix microfat and nanofat together depending on the structures being treated.
Each structure is then injected individually under ultrasound guidance, with x-ray confirmation added for certain joints, rather than relying on a single injection into the joint space.
Recovery and Follow-Up
After your injection, we recommend resting for the remainder of that day so your body can begin the healing process. Most patients have increased soreness for 3 to 7 days afterward, depending on the areas treated. Physical activity restrictions typically last 1 to 4 weeks, with a gradual return to full activity guided by your response, and for most patients we refer to a physical therapist who designs a rehabilitation plan specific to your treatment and goals.
In our clinic, most patients start to notice a response within the first 4 weeks, and improvement typically continues building through the first 6 months.
We schedule follow-up assessments to track your progress using our outcome registry, giving both you and our team objective data on how your treatment is working.
Schedule a 2-hour evaluation for your chronic joint or nerve pain at our Gilbert, AZ clinic.
What results can you expect from MFAT?
Most patients who respond to MFAT start to see that response within the first 4 weeks, and healing typically continues out to a full year, with the majority of the improvement arriving in the first 6 months. Response is tracked rather than assumed: every case is followed in our outcome registry over that first year.
One pattern is unique to stem cell therapy and worth knowing in advance. Some patients feel a significant drop in pain in the first 7 to 14 days after the injection, because the injected cells release natural anti-inflammatory compounds and the body's own opioid-like pain relievers. That early relief wears off after a few weeks, and losing it does not mean the procedure failed. The true healing response builds on the slower timeline above.
Our retreatment philosophy is the same as for our other procedures: one treatment, then we track your response over a full year rather than scheduling a series. In a small percentage of cases we add a booster PRP injection around the 3 to 6 month mark, since some early research suggests it may improve outcomes. For patients using stem cell therapy as a last resort before surgery, we will say so when surgery is the better next step.
Outcome Snapshot
In our registry, 94% of stem cell cases with a completed six-month satisfaction survey were rated satisfied or extremely satisfied, and above 95% with completed twelve-month case responses were as well. Among the cases with completed safety follow-up in our registry, zero severe treatment-related adverse events have been reported, in registry data collected over more than 5 years. Registry data updated July 2026.
Who is a good candidate for MFAT?
MFAT is typically a good fit for adults whose chronic joint, tendon, or nerve-entrapment pain has not responded to conservative care and who want a stem-cell-based option without a bone marrow draw. Our 2-hour evaluation is designed to confirm this for your specific situation.
If you see yourself in the list below, MFAT may be worth exploring:
- Chronic pain for 3 or more months originating from a joint, tendon, ligament, or a specific nerve entrapment
- Failed conservative care such as physical therapy, chiropractic, massage, or medications
- Cortisone that helped temporarily but wore off
- Looking for non-surgical options before committing to a joint replacement or other surgery
- Wanting structure-specific treatment that targets the exact tissues generating your pain
- Willing to invest in your health, as these are cash-pay procedures
Our clinic is in Gilbert, AZ. Patients travel in from out of state and internationally, and we schedule the evaluation and the procedure in a single trip for traveling patients.
During your evaluation, we will assess whether MFAT is the right approach for your specific condition, or whether a different regenerative treatment such as bone marrow concentrate or PRP might be more appropriate.
If you are unsure whether orthobiologic injections like PRP or stem cell therapy are appropriate, or you are traveling from outside the Phoenix area, you can also call and ask about a brief 15 minute discovery call.
Frequently Asked Questions About MFAT
What is MFAT treatment?
MFAT treatment is a stem cell therapy that uses a small amount of the patient's own fat, mechanically processed the same day into tiny cell-rich clusters and injected into damaged joints, tendons, or other painful structures under image guidance. The clusters deliver stem and stromal cells, growth factors, and a natural scaffold that support the tissue's healing response.
Is MFAT the same as stem cell therapy?
Yes, MFAT is one form of stem cell therapy: it delivers the patient's own fat-derived stem and stromal cells. The other common form, also made from the patient's own cells, is bone marrow concentrate (BMAC), and both are considered stem cell therapy.
Is MFAT FDA approved?
No, MFAT is not an FDA-approved treatment for any orthopedic condition. It is a same-day use of the patient's own tissue prepared with cleared devices under the FDA's minimal-manipulation framework. The FDA regulates the devices and products involved, not the procedure itself.
How long does pain relief from an MFAT injection last?
Published studies document meaningful relief through 6 to 12 months after a single MFAT injection, and a small 3-year study suggests 1-year improvements were maintained in the 22 patients who needed no further treatment, most of whom also had knee surgery alongside the injection. Durability in any individual case depends on the diagnosis and the severity of the damage.
What is the difference between MFAT and PRP?
MFAT delivers the patient's own fat-derived cells and tissue scaffold, making it a stem cell therapy, while PRP concentrates platelets and growth factors from blood and delivers no stem cells. A randomized knee arthritis trial indicates the two produce similar improvement at 6 months, with no difference detected between them, so the choice usually rests on the diagnosis, severity, and patient factors rather than raw effectiveness.
Is MFAT a same-day procedure?
Yes, MFAT is a same-day procedure: because the fat is processed mechanically rather than cultured, the harvest, processing, and injection all happen in a single visit, and most patients go home shortly after the injection.
What are the risks of MFAT injections?
The most common issues reported after MFAT in a 2022 hip osteoarthritis study by Heidari et al. in the Journal of Clinical Medicine were joint pain after the injection and pain at the fat-harvest site. Across 19 randomized trials of fat-derived treatments, no serious adverse events were reported, and that hip study specifically reported no infections or blood-clot complications. Because MFAT uses your own tissue, the risk of adverse reaction is extremely low, though every injection carries small risks such as bleeding or infection.
Is MFAT covered by insurance in Arizona?
No, MFAT is not typically covered by insurance, in Arizona or elsewhere. It is a cash-pay procedure, and HSA or FSA funds can be used. The cost depends on the number and complexity of structures treated.
Still have questions? The best way to get answers is a conversation. Call 480-508-4226.
Medical Disclaimer: MFAT is an autologous, minimal-manipulation procedure using devices cleared for tissue processing. It is not an FDA-approved treatment for any orthopedic or nerve condition. All injection procedures at Regenerative Performance are performed under ultrasound or x-ray guidance. Results vary by patient and condition. The information on this page is educational and does not constitute medical advice. We need to evaluate your specific situation before determining if MFAT makes sense for you.
About Dr. Drew Timmermans
Dr. Drew Timmermans, ND, RMSK, is a naturopathic physician and registered musculoskeletal sonographer (RMSK) practicing at Regenerative Performance in Gilbert, AZ. He specializes in orthobiologic injections, including PRP, stem cell therapy, prolotherapy, and nerve hydrodissection, using ultrasound and fluoroscopic guidance to treat the specific structures causing chronic pain rather than suppressing symptoms.
Patients from across Arizona and out of state see him for chronic joint and nerve pain that has not responded to physical therapy, cortisone, or standard orthopedic care. Read Dr. Timmermans's full bio.
References
- Baria M, Pedroza A, Kaeding C, et al. Platelet-Rich Plasma Versus Microfragmented Adipose Tissue for Knee Osteoarthritis: A Randomized Controlled Trial. Orthop J Sports Med. 2022;10(9). DOI: 10.1177/23259671221120678.
- Baria M, et al. Relationship of Body Mass Index on Patient-Reported Outcomes After Platelet-Rich Plasma Versus Microfragmented Adipose Tissue for Knee Osteoarthritis. Am J Phys Med Rehabil. 2024;103(11):1006-1011. DOI: 10.1097/phm.0000000000002499.
- Heidari N, et al. Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One Year. J Clin Med. 2022;11(4):1056. DOI: 10.3390/jcm11041056.
- Richter DL, Harrison JL, Faber L, et al. Microfragmented Adipose Tissue Injection Reduced Pain Compared With a Saline Control Among Patients With Symptomatic Osteoarthritis of the Knee During 1-Year Follow-Up: A Randomized Controlled Trial. Arthroscopy. 2025;41(2):248-260. DOI: 10.1016/j.arthro.2024.08.037.
- Zaffagnini S, Andriolo L, Boffa A, et al. Microfragmented Adipose Tissue Versus Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis: A Prospective Randomized Controlled Trial at 2-Year Follow-up. Am J Sports Med. 2022;50(11):2881-2892. DOI: 10.1177/03635465221115821.
- Fu H, Wang C. Micro-fragmented adipose tissue: An innovative therapeutic approach: A narrative review. Medicine (Baltimore). 2025;104(9):e41724. DOI: 10.1097/md.0000000000041724.
- Mautner K, et al. Functional Outcomes Following Microfragmented Adipose Tissue Versus Bone Marrow Aspirate Concentrate Injections for Symptomatic Knee Osteoarthritis. Stem Cells Transl Med. 2019;8(11):1149-1156. DOI: 10.1002/sctm.18-0285.
- Veronesi F, et al. Adipose Tissue-Derived Minimally Manipulated Products versus Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis: A Systematic Review of Clinical Evidence and Meta-Analysis. J Clin Med. 2024;13(1):67. DOI: 10.3390/jcm13010067.
- Batista JD, et al. Intra-articular adipose-derived cell therapies for knee osteoarthritis: a systematic review of randomized controlled trials. Front Med. 2026;13:1771008. DOI: 10.3389/fmed.2026.1771008.
- Everts PA, et al. The Regenerative Marriage Between High-Density Platelet-Rich Plasma and Adipose Tissue. Int J Mol Sci. 2025;26(5):2154. DOI: 10.3390/ijms26052154.
- Cicione C, et al. Micro-fragmented and nanofat adipose tissue derivatives: In vitro qualitative and quantitative analysis. Front Bioeng Biotechnol. 2023;11:911600. DOI: 10.3389/fbioe.2023.911600.
- Jeyaraman M, et al. Nanofat: A therapeutic paradigm in regenerative medicine. World J Stem Cells. 2021;13(11):1733-1746. DOI: 10.4252/wjsc.v13.i11.1733.
NOTE: This article provides general information to help the reader better understand regenerative medicine, nerve and musculoskeletal conditions, naturopathic approaches to pain, and related subjects. All content provided in this article, website, or any linked materials, including text, graphics, images, research, and outcomes, are not intended, and should not be used, as a substitute for direct medical advice, diagnosis, or treatment. Please always consult with a professional and licensed healthcare provider to discuss if any treatment is right for you.
Registry data from our single practice, powered by DataBiologics, is not a randomized clinical trial. Individual results may vary.